T Cell Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
30
NCT06420089
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 4, 2024
Completion: Jun 30, 2027
Loading map...